Thomas Wakim
analystMale0.0Global Dominance: 0.00%
Thomas Wakim is a health analyst at Bell Potter who specializes in the pharmaceutical and healthcare sectors. He has been vocal about the implications of the declining flu vaccination rates in the U.S., attributing them to a broader negative sentiment influenced by recent leadership changes at the Department of Health and Human Services.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Bell Potter health analyst Thomas Wakim stated that the declining US flu vaccination rates are clearly the result of increased negative sentiment across the broader US population.
CSL (ASX:CSL) How Trump’s antivaxxers helped trigger Aussie giant’s $50b implosionThe Sydney Morning Herald·
Australia· 2025-10-31
Australia· 2025-10-31
